Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Interim Management Statement

6 May 2010 07:00

Thursday 6 May 2010 SOPHEON PLC ("Sopheon" or the "Company") INTERIM MANAGEMENT STATEMENT Sopheon plc, the international provider of software and services that improvethe financial return from innovation and product development investments,announces its first interim management statement for the period since 1 January2010 to the date of this announcement, in line with the requirements of the EUTransparency Directive.Sopheon has continued to add business since the end of last year, building onthe improved performance of the fourth quarter. Since the start of 2010, wehave closed 12 new and extension license orders. Business from existingcustomers continues to hold up well. Revenue visibility for the full year fromcontracted business and recurring revenue streams now stands at £5.6 million,compared to £4.8 million on 24 March, the time of our last update. Totalreported revenue for 2009 was £8.3 million. Operating costs before R&Dcapitalization were approximately £0.5 million lower in the first quarter of2010 compared to the first quarter of 2009, reflecting the fact that costadjustments taken last year took effect in the second quarter. Gross cashresources at the end of the first quarter of 2010 stood at £1.7 million.The market is responding favourably to the new product enhancements that weintroduced in 2009. Since the start of the year we have continued to innovateand deliver new solutions. Most recently, we announced the launch of www.isustain.com in partnership with Cytec Industries and the Beyond BenignFoundation. The site enables users to assess the sustainability of productformulations through an iSUSTAIN Green Chemistry Index rating, which can beindependently certified if required. Users that wish to migrate beyond a basiclevel of interaction with the site will be required to enter into paid-forsubscriptions.Our sales pipeline continues to show encouraging activity, and suggests aresurgent appetite amongst large corporations to make positive purchasedecisions where they perceive real business benefits. Predicting the timing andvalue of individual sales remains challenging, which can inevitably impact onthe business performance. However, major analyst organisations like Forrester,Gartner and IDC continue to see growing traction and opportunity in our chosenmarket. In December 2009, Forrester noted increasing interest and investment inproject and portfolio management tools for product development (PPM) and in thesame month Gartner noted that software that supports product strategy andplanning is gaining attention as a segment of the product lifecycle management(PLM) software market. Forrester also identified Sopheon as one of the clearmarket share leaders in the PPM space.

For further information contact:

Barry Mence, Chairman Sopheon plc Tel : + 44 (0) 1483 685 735 Arif Karimjee, CFO Sopheon plc Tel : + 44 (0) 1483 685 735 Justine James / Hansard Communications Tel : + 44 (0) 20 7245 1100 Kirsty Corcoran Floor van Maaren Citigate First Financial Tel : + 31 (0) 205 754 010 Catherine Leftley / Seymour Pierce Corporate Tel: +44 (0) 20 7107 8000 Jonathan Wright Finance About SopheonSopheon is an international provider of software and services thathelp organisations improve the business impact of product innovation. Sopheon'ssolutions automate and govern the innovation process, enabling companies toincrease revenue and profits from new products. Sopheon's solutions are used byindustry leaders throughout the world, including BASF, Cadbury, Corning,Electrolux, Honeywell, Motorola and SABMiller. Sopheon is listed on the AIMMarket of the London Stock Exchange and on the Euronext in the Netherlands. Formore information, please visit www.sopheon.com.

vendor
Date   Source Headline
30th Jan 201810:27 amRNSIssue of Equity
29th Jan 20187:00 amRNSTrading Update
4th Jan 20182:05 pmRNSSecond Price Monitoring Extn
4th Jan 20182:00 pmRNSPrice Monitoring Extension
4th Jan 20187:00 amRNSTrading Update
22nd Dec 20171:01 pmRNSHolding(s) in Company
22nd Dec 201712:37 pmRNSConversion of Loan Stock
8th Dec 20177:00 amRNSAmendment to the Terms of Convertible Loan Stock
9th Nov 20177:00 amRNSCertis Europe Partners with Sopheon
19th Oct 20177:00 amRNSSopheon Funding Award
11th Oct 201710:44 amRNSDirector/PDMR Shareholding
2nd Oct 20177:00 amRNSIssue of Equity
26th Sep 20177:00 amRNSSopheon "Leader" in Strategic Portfolio Management
5th Sep 20177:00 amRNSSopheon's Accolade Software beyond innovation
24th Aug 20177:00 amRNSHalf Yearly Report
21st Jul 201710:32 amRNSDirector Shareholdings
6th Jul 20177:00 amRNSAccolade Release 11.2
29th Jun 20177:00 amRNSNew Approach to Product Development with Accolade
13th Jun 201712:04 pmRNSDirector Shareholdings
8th Jun 201712:09 pmRNSResult of AGM
8th Jun 20177:00 amRNSAGM Statement
26th May 20174:33 pmRNSIssue of Equity
26th Apr 20173:50 pmRNSIssue of Equity
12th Apr 201712:01 pmRNSIssue of Equity
7th Apr 20171:37 pmRNSDirector Shareholdings
31st Mar 20177:00 amRNSDirector Shareholdings
31st Mar 20177:00 amRNSIssue of Equity
23rd Mar 20177:00 amRNSFinal Results
23rd Feb 20177:00 amRNSAccolade Release 11.1
16th Feb 20177:00 amRNSGrant of Options / PDMR dealing
30th Jan 20177:00 amRNSTrading Update
21st Nov 201611:50 amRNSIssue of Equity
3rd Nov 20168:00 amRNSAccolade Release 11.0
29th Sep 201612:41 pmRNSIssue of Equity
22nd Sep 20169:09 amRNSIssue of Equity
15th Sep 20163:09 pmRNSIssue of Equity
25th Aug 20167:00 amRNSHalf Yearly Report
28th Jul 20165:01 pmRNSHolding(s) in Company
26th Jul 201610:49 amRNSHolding(s) in Company
12th Jul 201610:48 amRNSHolding(s) in Company
29th Jun 20165:32 pmRNSDirector Dealing
16th Jun 20164:22 pmRNSDirector Dealing
14th Jun 20164:18 pmRNSDirector Dealing
10th Jun 20162:13 pmRNSDirector Dealing
9th Jun 201611:37 amRNSResult of AGM
9th Jun 20167:00 amRNSAGM Statement
31st May 20163:09 pmRNSIssue of Equity
5th May 20161:25 pmRNSHolding(s) in Company
4th May 20167:00 amRNSAccolade Release 10.3
3rd May 20161:27 pmRNSDirector Shareholdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.